Align Technology | ALGN - Operating Profit

Stock Price
171.87
Daily Change
1.27 0.74%
Monthly
-1.82%
Yearly
12.08%
Q2 Forecast
165.46

Align Technology reported $224.71M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
3M USD 1.21B 394M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Cardinal Health USD 763M 9M Dec/2025
Charles River Laboratories USD 75.82M 57.98M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
CVS Health USD 2.11B 836M Dec/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 538M 26M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Henry Schein USD 186M 12M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Masimo USD 83.9M 300K Dec/2025
McKesson USD 1.66B 159M Dec/2025
Mettler Toledo International USD 351.93M 57.73M Dec/2025
Revvity USD 145.83M 47.49M Dec/2025
Solventum Corp USD 105M 1.58B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veeva Systems USD 245.88M 5.02M Dec/2025
Waters USD 270.52M 78.4M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025
Zoetis USD 835M 101M Dec/2025